FDA Investigator Dr. Mark J Seaton, PhD

Dr. Mark J Seaton, PhD has conducted inspections on 94 sites in 6 countries as of 06 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
94
Last Inspection Date:
06 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, China, Austria, Canada, Taiwan
FDA Investigators that have inspected at least one site in common with Dr. Mark J Seaton, PhD:
Abdellah El Hajjam, Alan D Centi, Alexandra B Pitkin, Alicia M Mozzachio, Amber G Chung, Amber G Wardwell, Amir Alavi, Ana P Barido, Anastasia I Offordile, Andrea A Branche, Andrea George, PhD, Andrew M Barlow, Andrew R Wasko, Andria L Kuhlman, Angel K Sandhu, Angela Shepas, Anh M Lac, Anita R Michael, Ann Marie Karnick, Ann Marie Montemurro, Anna M Brannen, Anthony A Charity, Arianne L Motter, Arindam Dasgupta, PhD, Atul J Agrawal, Austin B Appler, Barbara A Rusin, Barbara J Holladay, Barbara J Rincon, Barbara J Wilcox, PhD, Barbara Janine Breithaupt, Betsy C Galliher, Bichsa T Tran, Binh T Nguyen, Brandi L Garbutt, Brandon J Brookens, Brandon L Mariner, Brandy N Lepage, Brian D Young, Byron Ho, DVM, Byungja E Marciante, Calvin B Koerner, Calvin W Edwards, Cara M Minelli, Carl A Anderson, Carl Lee, Carla C Tuite, Carmen Y Fisher, Carol Rivera Lopez, PhD, Carole L Jones, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, CDR Michael J Mero, Chaltu Nwakijra, Chamberlain, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Cote, RIC, Charlotte E Wilkins, Chase Bourke, PhD, Chelsea W Lamm, Ching Jeyg Chang, Christian D Lynch (CDL), Christina A Miller, Christina K Theodorou, Christine M Whitby, CSO, Christopher R Czajka, Christopher T Middendorf, Claudia Wrzesinski, Clinton D Priestley, Connie P Rezendes, Corey K Reno, Courtney N Long, Craig T Rybus, Crayton Lee, Crystal A Harlan, Ct Viswanathan, PhD, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Cynthia L Rakestraw, Cynthia White, Daniel J Roberts, Daniel R Azar, Daniel R Tammariello, Daniel W Cline, Darin S Wiegers, Dauksism, David J Hafner, David K Glasgow, David L Chon, David L Pearce, David P Vanhouten, Dawn C Olenjack, Dawn D Aiello, Deborah A Greco, Deborah G Haney Cozzone, Deborah H Cozzone, Debra Bower, Debra J Bennett, Debra Lboyd Seale, Dell S Moller, Denise L Burosh, Diane Cvan Leeuwen, Dina A Tallman, Donald B Mckechnie, Douglas A Campbell, Douglas W Gronski, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Dylan D Yao, MD, PhD, Edward D Mcdonald, Eias A Zahalka, Eileen A Liu, Emest F Bizjak, Emily Shacter, Eric L Dong, BS, Eric S Myskowski, Eric S Pittman, Erica L Nicoll, Erik A Bungo, Erika M Wilkerson, Erin L Mcfiren, Erin M Mcdowell, Farhana Khan, Francis J Eng, Frederick M Lochner, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gary J Hagan, Gayle S Lawson, Geoffrey K Kilili, George Pyramides, Gerald Feldman, Gerald M Feldman, PhD, Gerald W Kopp, Gloria A Milster, Grace P Santos, Greg K Keshishyan, Gregory E Beichner, Gregory W Smith, Gwyn G Dickinson, Hanna L Potter, Heika R Bounds, Heika R Tait, Henry K Lau, Himanshu Gupta, PhD, Hugh M Mcclure, II, Hyojong Kwon, PhD, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, James M Mason, James P Mcevoy, James P Stumpff, James R Evans, James W Plucinski, Jane M Kreis, Janet L Bowen, Janete F Guardia, Jasjeet K Sekhon, Jeanne Fringer, PhD, Jeanne J Thai, Jeffrey M Watson, Jennifer C Adams, Jennifer C Johnson, Jennifer L Jager, Jennifer M Gogley, Joan A Loreng, Joan T Briones, Joanne Hajoway, Joanne M Hajoway, Joanne M Schlossin, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, Jogy George, Johann M Fitch, John A Kadavil, PhD, Jonathan R Campos, Jose M Cayuela, Joseph Kutze, PhD, Joseph L Despins, PhD, Joseph P Iser, MD, Joseph R Haynes, Joseph T Dougherty, Joshua S Hunt, Juanita Banuelos, Judith A Paterson, Julian C Hanson, Julianne C Mccullough, Julie D Bringger, Junho Pak, Jyoti B Patel, PhD, Ka L Wong, Kara A Scheibner, PhD, Karen M Kondas, Katherine E Jacobitz, Kathleen S Tormey, Kathryn A Krentz, Kellia N Hicks, Kelly N Kerr, Kendra L Brooks, Kenneth Nieves, Kent A Conforti, Kent C Faul, Kerun Hardeo, Kevin P Foley, Kim Lthomas Cruse, Kimberly A Dux, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kujtim Sadiku, Kurt A Brorson, PhD, Laine P Myers, Lakisha M Williams, Lance Mde Souza, MBA, Laurie P Norwood, LCDR Jennifer H Rhyu, LCDR Margaret Edi Gennaro, LCDR Susan E Polifko, LCDR William H Bender, Li Hongpaul Yeh, PhD, Linda S Leja, Linda Thai, Linh Tu, Lisa Hayka, Lori J Silverstein, LT John M Mastalski, Luann Mckinney, Lynda L Lanning, Lynette P Salisbury, Mabel M Lee, Maida Henesian (NMI), Makini Cobourne Duval, PhD, Marcelo O Mangalindan, Jr, Marcia A Worley, Maria A Reed, Maria Pkelly Doggett, MBA, Marie K Kinkade, Marijo B Kambere, PhD, Mariza M Jafary, Marsha W Major, Martha Sullivan Myrick, Martin J Guardia, Martin K Yau, PhD, Mary E Storch, Mary Jeanet Mcgarry, Matthew C Watson, Maureen A Duckworth, Maureen A Wentzel, Melissa M Schafer, Meredith L Sheridan, Michael A Taylor, Michael F Skelly, PhD, Michael J Diskin, Michael J Nerz, Michael Serrano, Michael Shanks, MS, Michael T Cyrus, Michele M Falchek, Michelle J Hines, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Mike M Rashti, Min Shanmabel Liu, Minh D Phan, Morris Paul, Muralidhara B Gavini, PhD, Myrick, Nancy A Bellamy, Nancy L Neiger, Natalie A Mickelsen, DVM, Nathan R Moon, Nayan J Patel, Nebil A Oumer, Nicholas L Hunt, Nicholas Obiri, PhD, Nicole C Victoria, PhD, Niraj R Mehta, PhD, Norman K Starks, Nutan Mytle, Omotunde O Osunsanmi, Paquita F Segarra, Peter E Baker, Peter Kessler, PhD, Philip J Snoy, Phillip M Pontikos, Prabhu P Raju, Rachel C Harrington, Rafael Padilla, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Richard Heath Coats, Richard W Berning, Riley C Myers, PhD, Robert B Shibuya, MD, Robert D Tollefsen, Robert L Hummel, Roberta W Cunningham, Ronald R Ruff, Rory K Geyer, Rosanna M Goodrich, Rose Ashley, Rose Ljean Mary, Ruth A Williams, Sabine Francke, Sandra A Hughes, Sandra S Saniga, Scott B Laufenberg, Scott N Lim, Sean D Duke, Seng Ching Hwang, Seongeun Cho (Julia), PhD, Serge L Beaucage, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Sherry L Secrist, BLT DO, Sidney B Priesmeyer, Sony Mathews, Sripal R Mada, PhD, Stacey A Priest, Stanley Au, Stephanie A Slater, MS, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen J Kilker, Steven P Donald, Stuart W Russell, Subramanian Muthukkumar, PhD, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan T Hadman, Susanne M Richardson, MS RAC, Tahseen Mirza, Tammy L Chavis, Teena H Aiken, Thea C Grome, Theresa Kirkham (NMI), Theressa B Smith, Thomas E Friel, Thomas W Nojek, Thunder N Dunkijacobs, Thuy T Nguyen, LCDR, Tiffani D Wilson, Timothy C Grome, Todd J Maushart, Tong Zhou, Toyin B Oladimeji, Tracey Asinjen Wiersma, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Van Cliff, Vashti E Bocker, Vickie J Kanion, Vickie L Anderson, Victor J Gangi, Vlada Matusovsky, Walden H Lee, Whitney S Reynolds, William C Brenneman, William D Tingley, William J Leonard, William V Millar, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yangmin Ning, Yi Wang, PhD, Yiyue Zhang (nmi), PhD, Young M Yoon, Yvette I Henry, Yvette I Johnson, Yvette Mlacour Davis, Zhongren Wu

Dr. Mark J Seaton, PhD's Documents

Publish Date Document Type Title
January, 2001 EIR Bellasorte, Joseph R. - EIR, 2001-01-25
June, 2018 EIR Charles River Laboratories - EIR, 2018-06-28
March, 2016 FDA 483 GlaxoSmithKline LLC - Form 483, 2016-03-18
September, 2019 EIR Altasciences Preclinical Seattle, LLC - EIR, 2019-09-13
December, 2000 FDA 483 Micron Technologies, Inc. - Form 483, 2000-12-07
April, 2017 FDA 483 West China-Frontier Pharma Tech Co., Ltd. - Form 483, 2017-04-21
October, 2000 FDA 483 Charles River Laboratories, Inc. - Form 483, 2000-10-03
October, 2000 EIR Charles River Laboratories, Inc. - EIR, 2000-10-03
March, 2019 FDA 483 Wuxi Apptec Suzhou Co.,Ltd - Form 483, 2019-03-08
September, 2007 FDA 483 Genentech, Inc. - Form 483, 2007-09-21
October, 2000 FDA 483 Response Charles River Laboratories, Inc. - Form 483R, 2000-12-15
August, 2019 FDA 483 BioReliance Corporation - Form 483, 2019-08-08
March, 2019 FDA 483 JOINN Laboratories (Suzhou) - Form 483, 2019-03-15
July, 2018 EIR Calvert Laboratories, Inc. - EIR, 2018-07-25
January, 2020 FDA 483 Response Lovelace Biomedical Research Institute - Form 483R, 2020-02-20
February, 2008 EIR University of Colorado HSC Antiviral Pharmacology Laboratory - EIR, 2008-02-15
April, 2017 FDA 483 National Beijing Center For Drug Safety Evaluation And Resea - Form 483, 2017-04-28
July, 2017 FDA 483 Labcorp Bedford LLC. - Form 483, 2017-07-21
August, 2019 FDA 483 Response BioReliance Corporation - Form 483R, 2019-08-08
June, 2008 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2008-06-13
October, 2018 EIR Experimur, A Frontage Company - EIR, 2018-10-26
October, 2014 FDA 483 Charles River Laboratories - Form 483, 2014-10-10
August, 2016 FDA 483 JOINN Laboratories (Suzhou) - Form 483, 2016-08-12
April, 2014 FDA 483 Battelle Memorial Institute - Form 483, 2014-04-04
December, 2005 EIR Robert Litman, M.D. - EIR, 2005-12-14
May, 2020 FDA 483 Alturas Analytics, Inc. - Form 483, 2020-05-05
October, 2016 FDA 483 National Microbiology Laboratory - Form 483, 2016-10-19
September, 2019 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2019-09-13
November, 2018 FDA 483 Memorial Sloan Kettering Cancer Center - Form 483, 2018-11-09
August, 2017 FDA 483 Oeyama-Moto-Medical Group Foundation, LLC - Form 483, 2017-08-11
April, 2015 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2015-04-16
November, 2019 EIR Battelle Memorial Institute - EIR, 2019-11-08
April, 2008 EIR Allergan Sales, LLC - EIR, 2008-04-18
December, 2005 FDA 483 Robert Litman, M.D. - Form 483, 2005-12-14
October, 2018 FDA 483 Response Experimur, A Frontage Company - Form 483R, 2018-11-19
May, 2020 EIR Alturas Analytics, Inc. - EIR, 2020-05-05
March, 2018 EIR Frontage Laboratories, Inc. - EIR, 2018-03-08
March, 2024 FDA 483 BASi Gaithersburg, LLC - Form 483, 2024-03-29
June, 2002 EIR eResearch Technology - EIR, 2002-06-13
January, 2020 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2020-01-31
June, 2002 FDA 483 eResearch Technology - Form 483, 2002-06-13
September, 2017 EIR Shanghai Medicilon Inc. - EIR, 2017-09-15
March, 2016 EIR GlaxoSmithKline LLC - EIR, 2016-05-03
September, 2007 EIR Genentech, Inc. - EIR, 2007-09-21
January, 2020 EIR Lovelace Biomedical Research Institute - EIR, 2020-01-31
June, 2002 FDA 483 Response eResearch Technology - Form 483R, 2002-06-21
April, 2014 EIR Battelle Memorial Institute - EIR, 2014-04-04
August, 2019 EIR BioReliance Corporation - EIR, 2019-08-08
October, 2018 FDA 483 Experimur, A Frontage Company - Form 483, 2018-10-26
December, 2019 FDA 483 Vimta Labs Limited - Form 483, 2019-12-18
May, 2019 FDA 483 Pharmaron - Form 483, 2019-05-24
October, 2014 EIR Charles River Laboratories - EIR, 2014-10-10
May, 2024 FDA 483 Suzhou Xishan Zhongke Drug R&D, Co. Ltd. - Form 483, 2024-05-21
May, 2024 FDA 483 Joinn Laboratories Co. Ltd. - Form 483, 2024-05-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more